Identification of the synthetic cannabinoid‐type new psychoactive substance, CH‐PIACA, in seized material. Issue 9 (16th June 2022)
- Record Type:
- Journal Article
- Title:
- Identification of the synthetic cannabinoid‐type new psychoactive substance, CH‐PIACA, in seized material. Issue 9 (16th June 2022)
- Main Title:
- Identification of the synthetic cannabinoid‐type new psychoactive substance, CH‐PIACA, in seized material
- Authors:
- Pasin, Daniel
Nedahl, Michael
Mollerup, Christian Brinch
Tortzen, Christian
Reitzel, Lotte Ask
Dalsgaard, Petur Weihe - Abstract:
- Abstract: Synthetic cannabinoids (SCs) remain the largest class of new psychoactive substances (NPS), and while the number of NPS that are reported to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for the first time each year declines, the number of newly reported SCs still exceeds other NPS classes. This decline can be seen as a result of legislative changes by different jurisdictions which have sometimes transitioned to a more generalized approach when controlling substances by defining common structural scaffolds rather than explicit structures. While the consequences of such legislative changes have been expected over the years, the introduction of so‐called "class‐wide" bans puts further pressure on clandestine laboratories to synthesize compounds which are out of the scope of the legislation, and thus, these compounds are initially harder to detect and/or identify in the absence of analytical data. Recently, a SC with an indole‐3‐acetamide core‐linker scaffold, AD‐18 (i.e., ADB‐FUBIATA or ADB‐FUBIACA), was reported for the first time in China in 2021. Here, an additional cannabinoid with the indole‐3‐acetamide scaffold, N ‐c ycloh exyl‐2‐(1‐p entyl‐1 H ‐i ndol‐3‐yl)ac eta mide (CH‐PIACA), is reported which was identified for the first time in a seized material in Denmark. Structural characterization was performed using gas chromatography–mass spectrometry (GC–MS), liquid chromatography‐high‐resolution mass spectrometry (LC‐HRMS), and nuclearAbstract: Synthetic cannabinoids (SCs) remain the largest class of new psychoactive substances (NPS), and while the number of NPS that are reported to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for the first time each year declines, the number of newly reported SCs still exceeds other NPS classes. This decline can be seen as a result of legislative changes by different jurisdictions which have sometimes transitioned to a more generalized approach when controlling substances by defining common structural scaffolds rather than explicit structures. While the consequences of such legislative changes have been expected over the years, the introduction of so‐called "class‐wide" bans puts further pressure on clandestine laboratories to synthesize compounds which are out of the scope of the legislation, and thus, these compounds are initially harder to detect and/or identify in the absence of analytical data. Recently, a SC with an indole‐3‐acetamide core‐linker scaffold, AD‐18 (i.e., ADB‐FUBIATA or ADB‐FUBIACA), was reported for the first time in China in 2021. Here, an additional cannabinoid with the indole‐3‐acetamide scaffold, N ‐c ycloh exyl‐2‐(1‐p entyl‐1 H ‐i ndol‐3‐yl)ac eta mide (CH‐PIACA), is reported which was identified for the first time in a seized material in Denmark. Structural characterization was performed using gas chromatography–mass spectrometry (GC–MS), liquid chromatography‐high‐resolution mass spectrometry (LC‐HRMS), and nuclear magnetic resonance (NMR) spectroscopy. Abstract : A new synthetic cannabinoid, N ‐c ycloh exyl‐2‐(1‐p entyl‐1 H ‐i ndol‐3‐yl)ac eta mide (CH‐PIACA), with the indole‐3‐acetamide scaffold was identified in a seized material in Denmark and characterized using gas chromatography–mass spectrometry (GC–MS), ultrahigh performance liquid chromatography‐quadrupole time‐of‐flight‐mass spectrometry (UPLC‐QTOF‐MS), and nuclear magnetic resonance (NMR) spectroscopy. This marks the second synthetic cannabinoid with this scaffold that has been reported with further analogs anticipated to emerge in the near future. … (more)
- Is Part Of:
- Drug testing and analysis. Volume 14:Issue 9(2022)
- Journal:
- Drug testing and analysis
- Issue:
- Volume 14:Issue 9(2022)
- Issue Display:
- Volume 14, Issue 9 (2022)
- Year:
- 2022
- Volume:
- 14
- Issue:
- 9
- Issue Sort Value:
- 2022-0014-0009-0000
- Page Start:
- 1645
- Page End:
- 1651
- Publication Date:
- 2022-06-16
- Subjects:
- drug seizure -- NPS -- synthetic cannabinoids
Drugs -- Analysis -- Periodicals
Drug testing -- Periodicals
Chemistry, Forensic -- Periodicals
615.1901 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1942-7611 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=110501 ↗
http://www3.interscience.wiley.com/journal/121408477/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/dta.3333 ↗
- Languages:
- English
- ISSNs:
- 1942-7603
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.424000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23231.xml